Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · Real-Time Price · USD
0.6705
-0.0224 (-3.23%)
At close: Sep 15, 2026, 4:00 PM EDT
0.6770
+0.0065 (0.97%)
After-hours: Sep 15, 2026, 6:08 PM EDT
Tenaya Therapeutics Employees
Tenaya Therapeutics had 70 employees as of December 31, 2025. The number of employees decreased by 27 or -27.84% compared to the previous year.
Employees
70
Change (1Y)
-27
Growth (1Y)
-27.84%
Revenue / Employee
$19,071
Profits / Employee
-$1,473,071
Market Cap
150.35M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 70 | -27 | -27.84% |
| Dec 31, 2024 | 97 | -43 | -30.71% |
| Dec 31, 2023 | 140 | -1 | -0.71% |
| Dec 31, 2022 | 141 | 35 | 33.02% |
| Sep 30, 2022 | 140 | 40 | 40.00% |
| Jun 30, 2022 | 135 | 50 | 58.82% |
| Mar 31, 2022 | 125 | 50 | 66.67% |
| Dec 31, 2021 | 106 | 31 | 41.33% |
| Sep 30, 2021 | 100 | 25 | 33.33% |
| Jun 30, 2021 | 85 | - | - |
| Mar 31, 2021 | 75 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| LENZ Therapeutics | 152 |
| Molecular Partners AG | 134 |
| Immunic | 100 |
| Caribou Biosciences | 97 |
| Milestone Pharmaceuticals | 38 |
| Jyong Biotech | 27 |
| Unicycive Therapeutics | 22 |
| Spruce Biosciences | 22 |
TNYA News
- 1 day ago - Tenaya Therapeutics granted RMAT designation from FDA for TN-401 - TheFly
- 1 day ago - Tenaya Therapeutics Granted U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for TN-401 for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy - GlobeNewsWire
- 4 days ago - Tenaya Therapeutics Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 12 days ago - Tenaya Therapeutics to Participate in Upcoming September Investor Conferences - GlobeNewsWire
- 5 weeks ago - Tenaya Therapeutics Transcript: Canaccord Genuity's 46th Annual Growth Conference - Transcripts
- 5 weeks ago - Tenaya Therapeutics reports Q2 EPS (20c), consensus (7c) - TheFly
- 5 weeks ago - Tenaya Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 5 weeks ago - Tenaya Therapeutics Quarterly report: Q2 2026 - Filings